{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:02:10Z","timestamp":1793041330935,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ajo.2015.04.025","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T22:28:58Z","timestamp":1429568938000},"page":"313-321.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study"],"prefix":"10.1016","volume":"160","author":[{"given":"Peter A.","family":"Campochiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2308-1910","authenticated-orcid":false,"given":"Gulnar","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahreem A.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-9094","authenticated-orcid":false,"given":"Raafay","family":"Sophie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard S.","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleema","family":"Kherani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Zimmer-Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2371-727X","authenticated-orcid":false,"given":"Ian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-628X","authenticated-orcid":false,"given":"Yannis","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrit","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2015.04.025_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mt.2008.10","article-title":"Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator","volume":"16","author":"Campochiaro","year":"2008","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.ajo.2015.04.025_bib2","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.ophtha.2010.03.060","article-title":"Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusion: two-year outcomes","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion:6-month results of the phase III CRUISE study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2015.04.025_bib4","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: 12-month outcomes of a phase III study","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2015.04.025_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","article-title":"Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study","volume":"118","author":"Brown","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2015.04.025_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajo.2012.09.026","article-title":"Intravitreal alflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS Study","volume":"155","author":"Brown","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.025_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ophtha.2012.09.032","article-title":"Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion","volume":"120","author":"Campochiaro","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.025_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajo.2013.05.039","article-title":"Long term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion","volume":"156","author":"Sophie","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2015.04.025_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: The RETAIN Study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0092-8674(90)90396-V","article-title":"Transciptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction","volume":"62","author":"Yang-Yen","year":"1990","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0092-8674(90)90397-W","article-title":"Runctional antagonism between oncoprotein c-Jun and the glucocorticoid receptor","volume":"62","author":"Schule","year":"1990","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ajo.2015.04.025_bib12","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","article-title":"A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP1","volume":"13","author":"Heck","year":"1994","journal-title":"EMBO J"},{"issue":"10","key":"10.1016\/j.ajo.2015.04.025_bib13","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2015.04.025_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.1999.0754","article-title":"GDNF family neurotrophic factor signaling: four masters, one servant?","volume":"13","author":"Airaksinen","year":"1999","journal-title":"Mol Cell Neurosci"},{"issue":"12","key":"10.1016\/j.ajo.2015.04.025_bib15","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1074\/jbc.M008279200","article-title":"Human glial cell line-derived neurotrophic factor receptor alpha4 is the recepor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells","volume":"276","author":"Lindahl","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.025_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(01)00012-0","article-title":"The GDNF\/RET signaling pathway and human diseases","volume":"12","author":"Takahashi","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"14","key":"10.1016\/j.ajo.2015.04.025_bib17","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1073\/pnas.152535899","article-title":"Effects of cerebral ischemia in mice deficient in persephin","volume":"99","author":"Tomac","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1016\/j.ajo.2015.04.025_bib18","doi-asserted-by":"crossref","first-page":"22190","DOI":"10.1016\/S0021-9258(18)41653-5","article-title":"Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component","volume":"267","author":"Breviario","year":"1992","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.ajo.2015.04.025_bib19","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.4049\/jimmunol.175.12.8303","article-title":"TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK","volume":"175","author":"Han","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.102.6.636","article-title":"PTX3, a prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans","volume":"102","author":"Peri","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajo.2015.04.025_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2007.08.013","article-title":"Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure","volume":"155","author":"Suzuki","year":"2008","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ajo.2015.04.025_bib22","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.ATV.0000015595.95497.2F","article-title":"Production of the long pentraxin PTX3 in advanced atherosclerotic plaques","volume":"22","author":"Rolph","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.ajo.2015.04.025_bib23","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ajo.2015.04.025_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/2013.jamaophthalmol.228","article-title":"Association of inflammatory factors with macular edema in branch retinal vein occlusion","volume":"131","author":"Noma","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2015.04.025_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/IAE.0b013e3182993d74","article-title":"Pentraxin 3 and other infalmmatory factors in central retinal vein occlusion and macular edema","volume":"34","author":"Noma","year":"2014","journal-title":"Retina"},{"issue":"44","key":"10.1016\/j.ajo.2015.04.025_bib26","doi-asserted-by":"crossref","first-page":"29983","DOI":"10.1074\/jbc.M805631200","article-title":"Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells","volume":"283","author":"Doni","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.ajo.2015.04.025_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1073\/pnas.90.5.1937","article-title":"Scatter factor induces blood vessel formation in\u00a0vivo","volume":"90","author":"Grant","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ajo.2015.04.025_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S","article-title":"Hepatocyte growth factor\/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells","volume":"181","author":"Jiang","year":"1999","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib29","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1167\/iovs.05-0071","article-title":"Hepatocyte growth factor induces retinal vascular permeability via MAP-kinase and PI-3 kinase without altering retinal hemodynamics","volume":"47","author":"Clermont","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajo.2015.04.025_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/diacare.21.10.1759","article-title":"Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders","volume":"21","author":"Katsura","year":"1998","journal-title":"Diabetes Care"},{"issue":"6850","key":"10.1016\/j.ajo.2015.04.025_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35091000","article-title":"Identification of an angiogenic mitogen selective for endocrine gland endothelium","volume":"412","author":"LeCouter","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ajo.2015.04.025_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nm0902-913","article-title":"Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis","volume":"8","author":"LeCouter","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.025_bib33","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/S0021-9258(17)41717-0","article-title":"Activin-A binds to a heterotrimeric receptor complex on the vascular endothelial cell surface. Evidence for a type 3 activin receptor","volume":"269","author":"McCarthy","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.ajo.2015.04.025_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1507\/endocrj.K06-222","article-title":"Activin A as a critical mediator of capillary formation: interaction with the fibroblast growth factor action","volume":"54","author":"Hayashi","year":"2007","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.025_bib35","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9440(10)63216-6","article-title":"Activin A in the regulation of corneal neovascularization and vascular endothelial growth factor expression","volume":"164","author":"Poulaki","year":"2004","journal-title":"Am J Pathol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939415002287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939415002287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:13:09Z","timestamp":1757596389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939415002287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0002939415002287"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2015.04.025","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2015.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}